Chemotherapeutics for acute erythroid leukemia: research, present and future

Z Liao, J Li, J Wu, J Liu, S Sun - Current Molecular Medicine, 2021 - ingentaconnect.com
… like a low dose of cytarabine or hypomethylating agents is … Anthracycline antibiotics
overcoming multidrug resistance … the extra function of PU.1 independent of GATA-1. Epigenetic …

The Impacts and Changes Related to the Cancer Drug Resistance Mechanism

P Varshney, V Sharma, D Yadav… - Current drug …, 2023 - ingentaconnect.com
… sette transporters and developing multidrug resistance inhibitors, are … patients often take
cytarabine (ara-C), a nucleoside-… The anthracycline-modified drugs annamycin and doxorubicin-…

[HTML][HTML] Myeloid cell leukemia-1: A formidable barrier to anticancer therapeutics and the quest of targeting it

P Sulkshane, T Teni - Exploration of Targeted Anti-tumor Therapy, 2022 - ncbi.nlm.nih.gov
… upon treatment with cytarabine- and anthracycline-based … Proteasome inhibitors like
bortezomib (velcade) and … its prosurvival functions through mechanisms that are independent of its …

[HTML][HTML] Tumour microenvironment stress promotes the development of drug resistance

NA Seebacher, M Krchniakova, AE Stacy, J Skoda… - Antioxidants, 2021 - mdpi.com
Multi-drug resistance (MDR) is a leading cause of cancer-… Further, many antineoplastic
compounds, including anthracyclines, … Resistance to cytarabine, 5-fluorouracil or oxaliplatin in …

[HTML][HTML] The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer Treatment

N Merjaneh, M Hajjar, YW Lan, VV Kalinichenko… - Cancers, 2024 - mdpi.com
… treatment with thiostrepton or bortezomib and TMZ restores … ) expression, a known culprit
in multidrug resistance [88]. … Cytarabine and anthracycline are the standard treatments for …

Combining histone deacetylase inhibitors with other anticancer agents as a novel strategy for circumventing limited therapeutic efficacy and mitigating toxicity

SA Ganai, SA Ganai - Histone Deacetylase Inhibitors in Combinatorial …, 2020 - Springer
… induction and suppression of multidrug resistance gene 1/MDR1, … along with doxorubicin
(anthracycline antibiotic) induced … As expected bortezomib increased bortezomib triggered …

Molecular targeting therapies for neuroblastoma: Progress and challenges

A Zafar, W Wang, G Liu, X Wang, W Xian… - Medicinal research …, 2021 - Wiley Online Library
… inhibitors (topotecan) and anthracyclines. However, the … been found to cause multidrug
resistance in NB cells. Thus, … and induces cell cycle arrest, and also bortezomib treatment …

Selective targeting of antiapoptotic BCL‐2 proteins in cancer

AC Timucin, H Basaga, O Kutuk - Medicinal research reviews, 2019 - Wiley Online Library
… and navitoclax potentiated the effect of bortezomib in the OPM-2 … or cytarabine with venetoclax
synergistically induced cell … of a MAPK-independent inhibition mechanism that could lead …

[HTML][HTML] New drugs are not enough‑drug repositioning in oncology: An update

RG Armando… - … Journal of Oncology, 2020 - spandidos-publications.com
… CPZ can circumvent multi-drug resistance in cancer cells (91)… agents cytarabine, etoposide
and daunorubicin in vitro, and … of 99 patients with anthracycline-resistant metastatic breast …

Farnesyltransferase Inhibitors: Current and Prospective Development for Hematologic Malignancies

JE Karp - Innovative Leukemia and Lymphoma Therapy, 2019 - taylorfrancis.com
… to the presence of multidrug resistance phenotype, which … resistance to tipifamib and
resistance to anthracyclines or … Tipifarnib and bortezomib are synergistic and overcome cell